Melanoma News and reporting on melanoma. Multiomic Profiling Uncovers Predictors of Melanoma Response to Immunotherapy A model based on the results could predict treatment response but was less able to forecast resistance, suggesting heterogeneous mechanisms. Ex Vivo Drug Resistance, Sensitivity Screening Explored for Treating Metastatic Melanoma Premium After a promising pilot study, researchers at the University of Helsinki are starting a larger investigation of patients' response to drugs selected via this method. Foundation Medicine Test Nabs FDA Approval as CDx for BRAF Inhibitor Therapeutics for Melanoma FoundationOneCDx will also automatically be a companion diagnostic for future BRAF inhibitors approved by the FDA that target specific BRAF mutations. Deepcell, University of Zurich Partner to Study Melanoma Microenvironment Investigators will use Deepcell’s AI-powered platform to isolate cancer cells, profile the tumor microenvironment, and study cell phenotype and function. UK Researchers Show Cytotoxic T-Cell Level Predicts Melanoma Immunotherapy Response A Science Immunology paper details how patients with more cytotoxic effector T cells in peripheral blood at baseline respond better to checkpoint inhibitors. Sep 16, 2021 Castle Biosciences Receives New York State Approval for DecisionDx DiffDx-Melanoma Test Aug 24, 2021 Castle Biosciences Awarded VA Supply Contract for Melanoma Test Jul 15, 2021 Germline Loss-of-Function Variants in ATM Gene May Contribute to Melanoma Predisposition Jul 9, 2021 Integrated Tumor, Microbiome Features Influence Immunotherapy Combo Effects in Advanced Melanoma Jul 2, 2021 Astronomy, Biology Come Together for Cancer Biomarker Discovery Premium May 14, 2021 DermTech Q1 Revenues up 62 Percent May 10, 2021 Castle Biosciences Q1 Revenues Up 31 Percent Mar 8, 2021 Castle Biosciences Q4 Revenues Down 2 Percent Feb 16, 2021 Circulating Tumor DNA Provides Prognostic Clues in Advanced BRAF-Mutated Melanoma Cases Jan 28, 2021 DermTech Using $144M Financing to Spur Marketing, Telemedicine Efforts For Molecular Melanoma Assay Premium Jan 22, 2021 Oppenheimer Initiates Coverage of DermTech With Outperform Rating Jan 19, 2021 OncoHost Raises $8 Million in Series B Funding Round Dec 23, 2020 Personalis Sees New Neoantigen Platform Driving Improved Immunotherapy Prediction Premium Dec 14, 2020 Craig-Hallum Initiates Coverage of DermTech With Buy Rating Dec 10, 2020 Apis Assay Technologies, Moffitt Cancer Center to Evaluate RNA Biomarkers for Cancer Progression Dec 3, 2020 Local Coverage Determinations Roundup: Castle Bio Nov 18, 2020 IsoPlexis Targets New Market Segments With Cheaper, More Flexible Single-Cell Proteomic Systems Premium Nov 16, 2020 Somatic Mutations in Lung Cancer Patients With HLA Supertype B44 Influence Immunotherapy Response Nov 9, 2020 Castle Biosciences Q3 Revenues Up 3 Percent Nov 6, 2020 Medicare Administrative Contractor CGS Aligns Coverage for Melanoma Risk Stratification Tests Load More Breaking News In Ongoing False Advertising Suit, Judge Allows Natera Counterclaims Against Guardant Health Centogene Strikes Rare Disease Target Discovery Deal With Insilico Medicine Dilated Cardiomyopathy Gene Mutations Point to Possible Therapeutic Strategy Ginkgo Bioworks Acquires Massachusetts COVID-19 Testing Firm Mainz Biomed Taps DCN Dx to Aid European Study of Enhanced ColoAlert Assay Parse Biosciences Partners With Research Instruments for Southeast Asia Distribution The Scan Transplant Tests Edited Pig Kidneys The Associated Press reports a University of Alabama-Birmingham team transplanted genetically modified pig kidneys into a brain-dead human patient. UK Changes Some Gene-Edited Crop Rules A new law may enable gene-edited crops to be sold in the UK within about five years, New Scientist says. Pill Works Against Omicron in Lab Pfizer's antiviral pill to treat SARS-CoV-2 appears to work against the Omicron variant, the Wall Street Journal reports. Nature Papers Find Genetic Risk Factor for Smell, Taste Loss in COVID-19; Analyze TB Granulomas In Nature this week: genome-wide association study find locus linked to the risk COVID-19 patients losing their sense of taste or smell, and more.